GENLISA Human Von Hippel Lindau Tumor Suppressor (VHL) ELISA

The GENLISA Human Von Hippel Lindau Tumor Suppressor (VHL) ELISA includes features like: - Ready to use protocol with break-apart wells for ease of use - Standardisation and High Reproducibility - Lot to Lot Consistency - Accuracy and Precision Validated against seven points for a “GOLD RING” Standard Quality ELISA - the benchmark sign for Krishgen Quality. The The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be human serum, plasma, biological fluids and cell culture supernatant. The kit uses indirect sandwich assay with double antibodies - capture and detection to ensure a high degree of sensitivity and specificity in the estimation of Von Hippel Lindau Tumor Suppressor (VHL)

Enzyme Immunoassay for the estimation of Human Von Hippel Lindau Tumor Suppressor (VHL) in human serum, plasma, cell culture supernatant and other biological samples. Validated for citrated/EDTA plasma only.

Human

Colorimetric, Absorbance measured at 450nm

Sandwich ELISA, Double Antibody

0; 0.3125; 0.625; 1.25; 2.5; 5; 10; 20 ng/ml

Serum, Plasma, Cell Culture Supernatant and other biological samples. Validated for citrated/EDTA Plasma only.

0.32 - 20 ng/ml

0.113 ng/ml

Shipped at Room Temperature or in gel pack to maintain temperature at 2-8 degrees Celsius